Galderma Group
GALD.SWApprovedGalderma Group is a premier dermatology-focused pharmaceutical company headquartered in Switzerland, serving healthcare professionals and patients worldwide with medical dermatology treatments, aesthetic solutions, and consumer skincare products. The company has established itself as a leader in dermatological innovation through its extensive research and development programs and comprehensive product portfolio. Following its successful IPO in 2024, Galderma continues to expand its global presence and advance its pipeline of dermatology treatments.
GALD.SW · Stock Price
Historical price data
AI Company Overview
Galderma Group is a premier dermatology-focused pharmaceutical company headquartered in Switzerland, serving healthcare professionals and patients worldwide with medical dermatology treatments, aesthetic solutions, and consumer skincare products. The company has established itself as a leader in dermatological innovation through its extensive research and development programs and comprehensive product portfolio. Following its successful IPO in 2024, Galderma continues to expand its global presence and advance its pipeline of dermatology treatments.
Technology Platform
Galderma leverages proprietary formulation technologies and drug delivery systems specifically designed for dermatological applications, combined with deep expertise in skin biology and inflammatory pathways.
FDA Approved Drugs
20Opportunities
Risk Factors
Competitive Landscape
Galderma competes in the dermatology market against diversified pharmaceutical companies like AbbVie and J&J, as well as specialized players like Allergan Aesthetics, with differentiation through its pure-play dermatology focus and comprehensive product portfolio.